Bitran JD - Search Results

1

Tandem high-dose chemotherapy supported by hematopoietic progenitor cells yields prolonged survival in stage IV breast cancer.

Bitran JD, Samuels B, Klein L, Hanauer S, Johnson L, Martinec J, Harris E, Kempler J, White W. Bitran JD, et al. Bone Marrow Transplant. 1996 Feb;17(2):157-62. Bone Marrow Transplant. 1996. PMID: 8640160 Clinical Trial.

2

High-dose intravenous melphalan: a review.

Samuels BL, Bitran JD. Samuels BL, et al. Among authors: bitran jd. J Clin Oncol. 1995 Jul;13(7):1786-99. doi: 10.1200/JCO.1995.13.7.1786. J Clin Oncol. 1995. PMID: 7602368 Review.

3

A phase II study of cyclophosphamide followed by PIXY321 as a means of mobilizing peripheral blood hematopoietic progenitor cells.

Roman-Unfer S, Bitran JD, Garrison L, Proeschel C, Hanauer S, Schroeder L, Johnson L, Klein L, Martinec J. Roman-Unfer S, et al. Among authors: bitran jd. Exp Hematol. 1996 Jun;24(7):823-8. Exp Hematol. 1996. PMID: 8647233 Clinical Trial.

4

Her2/neu overexpression is associated with treatment failure in women with high-risk stage II and stage IIIA breast cancer (>10 involved lymph nodes) treated with high-dose chemotherapy and autologous hematopoietic progenitor cell support following standard-dose adjuvant chemotherapy.

Bitran JD, Samuels B, Trujillo Y, Klein L, Schroeder L, Martinec J. Bitran JD, et al. Clin Cancer Res. 1996 Sep;2(9):1509-13. Clin Cancer Res. 1996. PMID: 9816327

5

Acute myeloid leukemia and myelodysplasia following intensive chemotherapy for breast cancer.

Roman-Unfer S, Bitran JD, Hanauer S, Johnson L, Rita D, Booth C, Chen K. Roman-Unfer S, et al. Among authors: bitran jd. Bone Marrow Transplant. 1995 Jul;16(1):163-8. Bone Marrow Transplant. 1995. PMID: 7581117

6

High-dose myeloablative therapy and autologous peripheral blood progenitor cell transplantation for elderly patients (greater than 65 years of age) with relapsed large cell lymphoma.

Bitran JD, Klein L, Link D, Kosirog-Glowacki J, Stewart C, Raack D, Sheahan P, Lisowski J, Rowen J. Bitran JD, et al. Biol Blood Marrow Transplant. 2003 Jun;9(6):383-8. doi: 10.1016/s1083-8791(03)00099-5. Biol Blood Marrow Transplant. 2003. PMID: 12813446 Free article.

7

A phase I study of ifosfamide and doxorubicin with recombinant human granulocyte colony-stimulating factor in stage IV breast cancer.

Bitran JD, Samuels BL, Marsik S, Gambino A, White L. Bitran JD, et al. Clin Cancer Res. 1995 Feb;1(2):185-8. Clin Cancer Res. 1995. PMID: 9815972 Clinical Trial.

8

High dose chemotherapy with autologous hematopoietic stem cell support in the treatment of refractory stage IV breast carcinoma.

Kaminer LS, Williams SF, Beschorner J, O'Brien S, Golick J, Bitran JD. Kaminer LS, et al. Among authors: bitran jd. Bone Marrow Transplant. 1989 Jul;4(4):359-62. Bone Marrow Transplant. 1989. PMID: 2505879

9

Dose intensification--a phase I study of ifosfamide with vinorelbine (Navelbine): rationale and study design in advanced non-small cell lung cancer.

Drinkard LC, Hoffman PC, Samuels BL, Watson S, Bitran JD, Golomb HM, Vokes EE. Drinkard LC, et al. Among authors: bitran jd. Semin Oncol. 1995 Apr;22(2 Suppl 5):30-7; discussion 41-4. Semin Oncol. 1995. PMID: 7537911 Clinical Trial.

10

Paclitaxel and ifosfamide: a multicenter phase I study in advanced non-small cell lung cancer.

Hoffman PC, Krauss SA, Drinkard LC, Masters GA, Samuels BL, Bitran JD, Golomb HM, Watson S, Vokes EE. Hoffman PC, et al. Among authors: bitran jd. Semin Oncol. 1995 Aug;22(4 Suppl 9):38-41. Semin Oncol. 1995. PMID: 7544026 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

170 results

Search Page

Filters